Knight Brian L, Patel Dilip D, Humphreys Sandy M, Wiggins David, Gibbons Geoffrey F
Lipoprotein Group, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Hospital, London W12 ONN, UK.
J Lipid Res. 2003 Nov;44(11):2049-58. doi: 10.1194/jlr.M300042-JLR200. Epub 2003 Aug 1.
Dietary supplementation with the peroxisome proliferator-activated receptor alpha (PPAR alpha) ligand WY 14,643 gave rise to a 4- to 5-fold increase in the expression of mRNA for the ATP binding cassette transporter A1 (ABCA1) in the intestine of normal mice. There was no effect in the intestine of PPAR alpha-null mice. Consumption of a high-cholesterol diet also increased intestinal ABCA1 expression. The effects of WY 14,643 and the high-cholesterol diet were not additive. WY 14,643 feeding reduced intestinal absorption of cholesterol in the normal mice, irrespective of the dietary cholesterol concentration, and this resulted in lower diet-derived cholesterol and cholesteryl ester concentrations in plasma and liver. At each concentration of dietary cholesterol, there was a similar significant inverse correlation between intestinal ABCA1 mRNA content and the amount of cholesterol absorbed. The fibrate-induced changes in the intestines of the normal mice were accompanied by an increased concentration of the mRNA encoding the sterol-regulatory element binding protein-1c gene (SREBP-1c), a known target gene for the oxysterol receptor liver X receptor alpha (LXR alpha). There was a correlation between intestinal ABCA1 mRNA and SREBP-1c mRNA contents, but not between SREBP-1c mRNA content and cholesterol absorption. These results suggest that PPAR alpha influences cholesterol absorption through modulating ABCA1 activity in the intestine by a mechanism involving LXR alpha.
用过氧化物酶体增殖物激活受体α(PPARα)配体WY 14,643进行膳食补充,可使正常小鼠肠道中ATP结合盒转运蛋白A1(ABCA1)的mRNA表达增加4至5倍。在PPARα基因敲除小鼠的肠道中则没有这种作用。食用高胆固醇饮食也会增加肠道ABCA1的表达。WY 14,643和高胆固醇饮食的作用并非相加性的。给正常小鼠喂食WY 14,643可降低肠道对胆固醇的吸收,无论膳食胆固醇浓度如何,这导致血浆和肝脏中饮食来源的胆固醇和胆固醇酯浓度降低。在每种膳食胆固醇浓度下,肠道ABCA1 mRNA含量与吸收的胆固醇量之间都存在类似的显著负相关。正常小鼠肠道中贝特类药物诱导的变化伴随着编码固醇调节元件结合蛋白-1c基因(SREBP-1c)的mRNA浓度增加,SREBP-1c是氧甾醇受体肝X受体α(LXRα)的已知靶基因。肠道ABCA1 mRNA和SREBP-1c mRNA含量之间存在相关性,但SREBP-1c mRNA含量与胆固醇吸收之间不存在相关性。这些结果表明,PPARα通过一种涉及LXRα的机制调节肠道中的ABCA1活性来影响胆固醇吸收。